1. Effect of new olivacine derivatives on p53 protein level
- Author
-
Kazimierz Gąsiorowski, Beata Tylińska, Katarzyna Gębczak, Tomasz Gębarowski, and Benita Wiatrak
- Subjects
Pharmacology ,BALB 3T3 Cells ,Lung Neoplasms ,Cell growth ,Chemistry ,Mutant ,Antineoplastic Agents ,Apoptosis ,General Medicine ,Olivacine ,Precursor Cell Lymphoblastic Leukemia-Lymphoma ,Small molecule ,Rhodamine 123 ,chemistry.chemical_compound ,Mice ,Biochemistry ,Cell culture ,Mutant protein ,A549 Cells ,Cell Line, Tumor ,Animals ,Humans ,Ellipticines ,Tumor Suppressor Protein p53 - Abstract
BackgroundThe p53 protein is a transcription factor for many genes, including genes involved in inhibiting cell proliferation and inducing apoptosis in genotoxically damaged and tumor-transformed cells. In more than 55% of cases of human cancers, loss of the essential function of p53 protein is found. In numerous reports, it has been shown that small molecules (chemical compounds) can restore the suppressor function of the mutant p53 protein in tumor cells. The aim of this study was to evaluate the potential anticancer activity of three newly synthesized olivacine derivatives.MethodsThe study was performed using two cell lines—CCRF/CEM (containing the mutant p53 protein) and A549 (containing a non-mutant, wild-type p53 protein). The cells were incubated with olivacine derivatives for 18 h and then assays were carried out: measurement of the amount of p53 and p21 proteins, detection of apoptosis, cell cycle analysis, and rhodamine 123 accumulation assay (evaluation of P-glycoprotein inhibition). Multiple-criteria decision analysis was used to compare the anticancer activity of the tested compounds.ResultsEach tested compound caused the reconstitution of suppressor activity of the p53 protein in cells with the mutant protein. In addition, one of the compounds showed significant antitumor activity in both wild-type and mutant cells. For all compounds, a stronger effect on the level of the p53 protein was observed than for the reference compound—ellipticine.ConclusionsThe observed effects of the tested new olivacine derivatives (pyridocarbazoles) suggest that they are good candidates for new anticancer drugs.
- Published
- 2019